Matching articles for "antibaterials"
Drugs for Sexually Transmitted Infections
The Medical Letter on Drugs and Therapeutics • April 27, 2026; (Issue 1753)
This review includes recommendations for the
treatment of common sexually transmitted infections
(STIs) other than HIV and viral hepatitis in nonpregnant
adolescents and adults. Some of the indications...
This review includes recommendations for the
treatment of common sexually transmitted infections
(STIs) other than HIV and viral hepatitis in nonpregnant
adolescents and adults. Some of the indications and
dosages included here have not been approved by
the FDA.
In Brief: New Recommendations for Gonococcal Infection
The Medical Letter on Drugs and Therapeutics • May 3, 2021; (Issue 1623)
The CDC has issued new recommendations for
treatment of gonococcal infection. A single 500-mg
IM dose (1000 mg in patients weighing ≥150 kg) of the
third-generation cephalosporin ceftriaxone is now...
The CDC has issued new recommendations for
treatment of gonococcal infection. A single 500-mg
IM dose (1000 mg in patients weighing ≥150 kg) of the
third-generation cephalosporin ceftriaxone is now the
treatment of choice for patients with uncomplicated
urogenital, rectal, or pharyngeal gonorrhea.